Get started
Author

Richard L. Borison

ICI 204,636, an Atypical Antipsychotic
1996 · Richard L. Borison, Lisa A. Arvanitis, et al. · Journal of Clinical Psychopharmacology · 268
Risperidone: clinical safety and efficacy in schizophrenia.
1992 · R L Borison, A P Pathiraja, et al. · PubMed · 210
A Comparison of Venlafaxine, Trazodone, and Placebo in Major Depression
1994 · LYNN A. CUNNINGHAM, RICHARD L. BORISON, et al. · Journal of Clinical Psychopharmacology · 157
A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients
1995 · Hans-Jürgen Möller, Horst Müller, et al. · European Archives of Psychiatry and Clinical Neuroscience · 147
Chronic phenylethylamine stereotypy in rats: A new animal model for schizophrenia?
1977 · Richard L. Borison, Henri S. Havdala, et al. · Life Sciences · 95
Modulation of dopamine receptor sensitivity by estrogen.
1980 · J H Gordon, R L Borison, et al. · PubMed · 92
Multiple-Dose Pharmacokinetics of Clozapine in Patients
1987 · Miles G. Choc, Robert G. Lehr, et al. · Pharmaceutical Research · 90
BMY 14802, a Sigma Receptor Ligand for the Treatment of Schizophrenia
1994 · George R. Gewirtz, Jack M. Gorman, et al. · Neuropsychopharmacology · 63
Treatment approaches in Gilles de la Tourette syndrome
1983 · Richard L. Borison, Lolita Ang, et al. · Brain Research Bulletin · 62
Postsynaptic efficacy of dopamine: Possible suppression by estrogen
1980 · John H. Gordon, Roger A. Gorski, et al. · Pharmacology Biochemistry and Behavior · 60
Dopamine binding following prolonged haloperidol pretreament
1978 · Ana Hitri, William J. Weiner, et al. · Annals of Neurology · 59
Brain 2-phenylethylamine as a major mediator for the central actions of amphetamine and methylphenidate
1975 · Richard L. Borison, Aron D. Mosnaim, et al. · Life Sciences · 59
New pharmacological approaches in the treatment of Tourette syndrome.
1982 · R L Borison, L Ang, et al. · PubMed · 58
Clozapine withdrawal rebound psychosis.
1988 · R L Borison, B I Diamond, et al. · PubMed · 56
Enkephalins and nigrostriatal function
1978 · Bruce I. Diamond, Richard L. Borison · Neurology · 56
Phenylethylamine and brain function
1978 · Hector C. Sabelli, Richard L. Borison, et al. · Biochemical Pharmacology · 52
A new animal model for Tourette syndrome.
1982 · B I Diamond, M G Reyes, et al. · PubMed · 49
Lithium prevention of amphetamine-induced ?manic? excitement and of reserpine-induced ?depression? in mice: Possible role of 2-phenylethylamine
1978 · Richard L. Borison, Hector C. Sabelli, et al. · Psychopharmacology · 48
The Oral Dose-Effect Relationship for Fluvoxamine: a Fixed-Dose Comparison Against Placebo in Depressed Outpatients
1996 · Donna Walczak, Jeffrey Apter, et al. · Annals of Clinical Psychiatry · 47
The use of midazolam in acutely agitated psychiatric patients.
1990 · M Wyant, B I Diamond, et al. · PubMed · 47
Clinical Efficacy of Serotonin-Dopamine Antagonists Relative to Classic Neuroleptics
1995 · RICHARD L. BORISON · Journal of Clinical Psychopharmacology · 45
Antipsychotic Drug Action
1983 · Richard L. Borison, Ana Hitri, et al. · Clinical Neuropharmacology · 42
Biosynthesis of brain 2-phenylethylamine: Influence of decarboxylase inhibitors and d-amphetamine
1974 · Richard L. Borison, Aron D. Mosnaim, et al. · Life Sciences · 37
Changes in Peripheral Benzodiazepine Receptors in Patients with Panic Disorder and Obsessive-Compulsive Disorder
2008 · Donatella Marazziti, Alessandro Rotondo, et al. · Neuropsychobiology · 36
Recent Advances in the Pharmacotherapy of Schizophrenia
1997 · Richard L. Borison · Harvard Review of Psychiatry · 36
Works count: 115
Citation count: 2,674
H-index: 29
I10-index: 49
Year
Topic
Type